Dr. Parag Shah
![dr-parag-shah-gujarat-endocrine-centre-ellis-bridge-ahmedabad-diabetologist-doctors-4bofp1a-250](https://drparagendocrinologist.com/wp-content/uploads/2021/08/dr-parag-shah-gujarat-endocrine-centre-ellis-bridge-ahmedabad-diabetologist-doctors-4bofp1a-250.jpg)
Dr. Parag Shah is only the one, in whole of the state of Gujarat possessing the Super-specialty qualifications in Endocrinology.
D.M. (Endocrinology)
Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow, July 1997.
D.N.B. (Endocrinology)
National Board of Examinations, New Delhi, May 1997.
Organizing Secretary –ESICON 2015
- Member of European Society of Association of Diabetes, Indian Society of Bone Metabolism and Research
- Active Member of Endocrine Society in India
- Active Member of European Association of study in Diabetes
- Attends all major national and international meetings like American Diabetes Association, Endocrine Society (US), American Association of Clinical Endocrinologist EASD for last eight years.
![dr-parag-shah-gujarat-endocrine-centre-ellis-bridge-ahmedabad-diabetologist-doctors-4bofp1a-250](https://drparagendocrinologist.com/wp-content/uploads/2021/08/dr-parag-shah-gujarat-endocrine-centre-ellis-bridge-ahmedabad-diabetologist-doctors-4bofp1a-250.jpg)
Dr. Parag Shah is only the one, in whole of the state of Gujarat possessing the Super-specialty qualifications in Endocrinology.
D.M. (Endocrinology)
Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow, July 1997.
D.N.B. (Endocrinology)
National Board of Examinations, New Delhi, May 1997.
Organizing Secretary –ESICON 2015
- Member of European Society of Association of Diabetes, Indian Society of Bone Metabolism and Research
- Active Member of Endocrine Society in India
- Active Member of European Association of study in Diabetes
- Attends all major national and international meetings like American Diabetes Association, Endocrine Society (US), American Association of Clinical Endocrinologist EASD for last eight years.
Paper Presentations
- “Bone Metabolism alterations in Acromegaly: Reversibility following surgical treatment” at 26th Annual Conference of Endocrine Society India, Cochin, December 1-3, 1996.
- “Bone Metabolism alterations in Acromegaly: Reversibility following surgical treatment” at 26th Annual Meeting Japanese Society of Bone Mineral Research, Omiya, Japan.
- “Clinical profile and therapeutic outcome of Cushing’s Syndrome” at 26th Annual Conference of Endocrine Society India, Cochin, December 1-3, 1996.
- “Clinical profile and therapeutic outcome of Cushing’s Syndrome” at 3rd Annual Conference of Indian Association of Endocrine Surgeons, Lucknow, December 11-13. 1997.
- “Low Bone turnover state in Hypothyroidism: Reversal following thyroxine therapy” at 15th Annual meeting of Japanese Society of Bone Mineral Research, Omiya, Japan.
- “Markers of bone metabolism in Hyperthyroidism: Reversibility with treatment” at 26th Annual Conference of Endocrine Society of India, Cochin, December 1-3-1996.
- “Low Bone turnover state in Hypothyroidism: Reversal following thyroxine therapy” at 26th Annual Conference of Endocrine Society of India, Lucknow, December 17-19, 1997.
- “Tubercular Addison’s Disease: No improvement in hormonal profile after Anti tubercular therapy” at 25th Annual Conference of Endocrine Society of India, Ahmedabad, December 1-3, 1995.
- “Clinical profile and therapeutic outcome of Cushing Syndrome” at 26th Annual Conference of Endocrine Society of India, Cochin, December 1-3,1996.
- “Clinical profile and therapeutic outcome of Cushing Syndrome” at 3rd Annual Conference of Indian Association of Endocrine Surgeons, Lucknow, December 11-13,1997.
Poster display of interesting cases of “Metabolic Bone Disorders” at 1st CME on Metabolic Bone Disorders, Lucknow, December 16, 1997.
Participated as a Presenter (International)
- ISPAD- OCT 2012, JAPAN
- China Andrology Expert Input Forum on December 8, 2012, HONG KONG
- International Conference on Diabetes and Metabolism- NOV 2012, Seoul, KOREA
Advisory Member of MNCs like
- BI-Lilly
- MSD
- Bayer
- BMS
- Novo-Nordisk
- Sanofi-Aventis
Participated as a Presenter (National)
- ITSCON 2017
- ESICON 2016
- APICON 2016
- ITSCON 2016
- ESICON 2015 (Org secretary),
- ITSCON 2015
- APICON 2015
- ESICON 2014
- ITSCON 2014
- APICON 204
- ESICON 2013
- APICON- FEB 2013, Coimbatore
- RSSDI- OCT 2012, Chennai
- ESICON- DEC 2012, Kolkata
- ESICON- DEC 2011, Pune
- APICON- FEB 2009, Greater Noida
- RSSDI- Nov 2008, Hyderabad
Involved as Principal Investigator in Clinical Trials since 2005
- Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 2 Diabetes
- Safety and Efficacy of LY2189265 as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
- A Study to Examine the Effects of LY2189265 Once-Weekly Injection on Glucose Control and Safety in Asian Subjects
- Comparison of Premixed Insulin Lispro Low Mixture and Mid Mixture Regimens with Separate Basal and Bolus Insulin Injections in Patients with Type 2 Diabetes with Inadequate Glycemic Control on Oral Therapy who Consume Light Breakfast
- Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin
- A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes
- Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1)
- A MultiCentre, Randomised, Double-Blind, Placebo-Controlled Phase IV Trial to Evaluate the Effect of Saxagliptin on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischaemic Stroke in Patients With Type 2 Diabetes
- A Randomized, Double-Blind, Placebo and Active-Controlled, 4-Arm, Parallel Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy
- Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes
- Niacin/Laropiprant Tablet for South and Southeast Asians With Low HDL at Risk for Cardiovascular Disease
- Study To Assess the dietary Carbohydrate content of Indian diabetic population
- Multifaceted Determinants for Achieving Glycemic Control
- The International Diabetes Management Practice Study (IDMPS)
- Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents
- Comparison of once a week GLP 1 analogue with daily insulin Glargine in patient with T2DM
- A Study to evaluate the Efficacy and Safety of Insulin Detemir against Insulin NPH along With Metformin and Diet/Exercise in Children and Adolescents having Type 2 Diabetes
- Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan (LixiRam)
- Study to evaluate safety and efficacy of growth hormone in adolescent population